Exencial Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Exencial Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $397,467 - $505,231	-831 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $277,822 - $335,687	510 Added 158.88%	831 $465,000
Q2 2020 Aug 17, 2020	BUY	$493.32 - $643.92 $158,355 - $206,698	321 New	321 $200,000
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $304,242 - $447,459	-905 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$335.82 - $403.04 $105,783 - $126,957	315 Added 53.39%	905 $338,000
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $254,514 - $297,360	590	590 $264,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.